Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer
Background. The tyrosine kinase inhibitors (TKIs) are indicated for the treatment of locally advanced or metastatic progressive thyroid carcinoma (CDT), refractory to radioactive iodine. The following report describes the efficacy of lenvatinib administered through a nose-gastric tube (SNG) in a pat...
Main Authors: | Eleonora Molinaro, David Viola, Nicola Viola, Pierpaolo Falcetta, Francesca Orsolini, Liborio Torregrossa, Paola Vagli, Alessandro Ribechini, Gabriele Materazzi, Paolo Vitti, Rossella Elisei |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2019/6831237 |
Similar Items
-
Tako-tsubo Syndrome as First Manifestation in a Case of Pheochromocytoma Developed From a Non-functional Adrenal Incidentaloma
by: Pierpaolo Falcetta, et al.
Published: (2020-02-01) -
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
by: Alessandro Prete, et al.
Published: (2021-06-01) -
Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
by: David Viola, et al.
Published: (2018-10-01) -
Malposition of a nasogastric tube
by: Monish S Raut, et al.
Published: (2015-01-01) -
Nasogastric administration of lenvatinib solution in a mechanically ventilated patient with rapidly growing anaplastic thyroid cancer
by: Fumiaki Kawano, et al.
Published: (2020-08-01)